Search for: "Abbott Laboratories Inc."
Results 381 - 400
of 450
Sorted by Relevance
|
Sort by Date
19 May 2011, 9:12 pm
In Abbott Laboratories v. [read post]
31 May 2019, 9:47 am
Long post, lots of stuff to cover in this opinion.MillerCoors, LLC v. [read post]
10 Jul 2023, 11:54 am
Abbott Laboratories, Inc. (1982) 32 C3d 892, 899. [read post]
8 Feb 2010, 2:52 pm
In Abbott Laboratories v. [read post]
8 Dec 2015, 2:22 pm
And in another settlement, PharMerica Corp., the nation’s second largest nursing home pharmacy, agreed to pay the United States $9.25 million to resolve allegations that it solicited and received kickbacks from pharmaceutical manufacturer Abbott Laboratories in exchange for promoting the drug Depakote for nursing home patients. [read post]
10 Dec 2016, 11:31 am
Jeffrey-Allan Indus., Inc., 807 F.2d 955, 962 (Fed. [read post]
30 Dec 2013, 5:25 am
PLIVA, Inc., 713 F.3d 774 (5th Cir. 2013). [read post]
31 Oct 2011, 3:55 am
: Firehouse Restaurant Group, Inc. v. [read post]
20 Jan 2021, 9:50 am
The 2011 case found that Quest Diagnostics, which was the state’s largest provider of medical laboratory testing, was allegedly overcharging MediCal, California’s Medicaid program. [read post]
10 Mar 2011, 7:58 am
Abbott Laboratories forecast NeoProfen could be sold for $450-500 per treatment course. [read post]
30 Jun 2011, 5:00 am
Wyeth Laboratories, 510 F. [read post]
28 Oct 2011, 7:00 am
Abbott Laboratories, Inc., 259 F.3d 1226, 1235 (10th Cir. 2001) ([the prescribing nurse’s] “failure to read the label - a basic task which she was trained to perform - was an efficient intervening cause of [plaintiff’s] injury”) (applying Kansas law). [read post]
2 Oct 2008, 12:36 pm
Abbott Laboratories, 447 F.3d 861, 867 (5th Cir. 2006), the court blew out this type of claim, finding the defendant's warning about high blood pressure sufficient and that there was no need to go further ant tell doctors about what high blood pressure itself can cause. [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole) –… [read post]
14 Jul 2022, 8:16 am
BE CURLY. 6756639 6761425 B BRAYFIT 6761356 FRED BEAR 6761313 SWEAT.SNAP.SWISH. 6761296 HITCHED SUITES 6761257 CRAFTSBURY CONSULTING 6756568 MEETING MAVEN 6761203 KEEP THE GOOD GOING 6754217 DUTCH WAFFLE COMPANY DWC 6754206 ONLY NECESSITIES 6755960 INTERSTELLAR 6753548 SPIDERSCREED 6753542 SCREEDSAVER 6753288 SPACE ICE THE FUTURE OF COLD THERAPY 6753003 TIMEAN 6752998 SPIRITRAIN 6752992 ROTILLD 6752989 PICATU 6752987 EXRESOFLY 6752983 PRIDE & JOY 3000 6752982 DEENAP 6752528 KINDTRAP 6751866 DWC… [read post]
7 Apr 2010, 4:30 am
Reddy's Laboratories, Ltd. et al (Docket Report) Retin-A Micro (Tretinoin) – US: District Court E D Texas: Promote Innovation files false marking complaint against Ortho-McNeil based on marking of Retin-A Micro product (Patent Docs) Seasonique (Levonorgestrel, Ethinyl estradiol) – US: Teva receives favourable court decision regarding Seasonique (SmartBrief) (The IP Factor) T2007 (Diphenyl barbituric acid) – US: Taro receives patent for new drug T2007 (The IP Factor)… [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
15 Apr 2009, 4:44 am
Philip Morris Inc., 964 F. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
13 Feb 2009, 8:00 am
(IP Think Tank) (The IP ADR Blog) (Chicago Intellectual Property Law Blog) 50 years of scientific discovery and sharing in Antarctica may end thanks to patent greed (Techdirt) Take steps to limit the impact of licensee’s economic woes (Technology Transfer Tactics) Australia TMO delegate allows ‘ElvisFinance’ covering financial services to proceed to registration despite opposition: Elvis Presley Enterprises Inc v Elvis Jelcic (Australian Trade Marks… [read post]
